Cidara Therapeutics(CDTX) - 2020 Q2 - Quarterly Report
Cidara Therapeutics(CDTX)2020-08-13 20:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-36912 (Exact name of registrant as specified in its charter) Delaware 46-1537286 (State or Other Jurisdiction of Incorporation or Org ...